IMCV
iShares Morningstar Mid-Cap Value ETF
IMCV tracks a market-cap-weighted index of US midcap stocks companies selected based on their value characteristics.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.2 B
ASSETS UNDER MGMT
6 bp
EXPENSES
Fund Basics
| Inception date | Jun 28, 2004 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| PNC FINANCIAL SERVICES GROUP | 1.4 % |
| US BANCORP | 1.3 % |
| AUTOMATIC DATA PROCESSING | 1.3 % |
| 3M CO | 1.2 % |
| ELEVANCE HEALTH INC | 1.2 % |
| UNITED PARCEL SERVICE-CL B | 1.2 % |
| MONDELEZ INTERNATIONAL INC-A | 1.2 % |
| GENERAL MOTORS CO | 1.1 % |
| SCHLUMBERGER LTD | 1.1 % |
| CIGNA CORPORATION | 1.1 % |
Constituent Breakdown
| Number of holdings | 274 |
| Herfindahl-Hirschman Index | 57 |
| Wgt avg mkt cap (mns) | $44,459 |
| Large cap (>$10bn) | 97.6% |
| Mid cap ($2-10bn) | 0.2% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 97.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 95.2 % |
 |
IRELAND | 0.9 % |
 |
BRITAIN | 0.7 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 9.1% | 21.2% | 11.8% | 15.2% | 6.4% | 7.9% | 6.4% | -31.3% |
| Dividend Yield | 0.5% | 2.7% | 2.6% | 2.7% | 2.5% | 2.6% | 2.6% | -1.8% |
| Total Returns | 9.6% | 23.9% | 14.4% | 17.9% | 8.9% | 10.5% | 9.0% | -33.1% | Ann. Volatility | 11.8% | 11.7% | 14.9% | 14.3% | 16.6% | 19.7% | 21.2% | 29.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.68 | 47% |
| MSCI EAFE | 0.52 | 45% |
| MSCI Emg Mkts | 0.31 | 28% |
Liquidity Measures
| Avg. volume (000) | 24 |
| ADV traded (mns) | $2 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.09% |
Technical Indicators
| 30d moving avg. (EMA) | $89.44 |
| Relative strength (RSI) | 55 |
| MACD/Signal | 0.61/0.68 |
| Bollinger Bands (Upper/Lower) | $91.45/$88.41 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IMCV |
Expenses vs. IMCV |
ALTAR Score™ vs. IMCV |
|---|---|---|---|---|
| IMCB | iShares Morningstar Mid-Cap ETF | 60.4% | -2 bp | -1.9% |
| VOE | Vanguard Mid-Cap Value ETF | 57.7% | +1 bp | -0.2% |
| VO | Vanguard Mid-Cap ETF | 49.7% | -2 bp | -1.8% |
| FTA | First Trust Large Cap Value AlphaDEX Fund | 49.3% | +53 bp | +0.5% |
| GSEW | Goldman Sachs Equal Weight U.S. Large Cap Equity ETF | 43.6% | +3 bp | -1.9% |
| IWS | iShares Russell Mid-Cap Value ETF | 43.4% | +17 bp | -1.2% |
| SIZE | iShares MSCI USA Size Factor ETF | 43.1% | +9 bp | -1.6% |
| EUSA | iShares MSCI USA Equal Weighted ETF | 42.7% | +3 bp | -1.6% |
| FEX | First Trust Large Cap Core AlphaDEX Fund | 42.1% | +53 bp | -2.3% |
| XOEF | iShares S&P 500 ex S&P 100 ETF | 41.9% | +14 bp | -2.4% |
Risk and Returns: IMCV vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/24/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
7.7%
ALTAR SCORE™
87th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,397 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. IMCV's ALTAR Score™ is approximately 1.1 standard
deviations above the category average. This places IMCV in the 87th percentile
among funds in the category.
Sell-Side Consensus
$99.62
PRICE TARGET
+9.9%
UPSIDE